---
figid: PMC6967775__oncotarget-11-46-g001
figlink: pmc/articles/PMC6967775/figure/F1/
number: Figure 1
caption: 'In cancer cells, EGF or EGF-related ligands bind to EGFR and phosphorylate
  tyrosine kinase residues, activating three major signal transduction pathways: MAPK,
  PI3K/Akt and JAK/STAT, which promote cell survival. Upregulated PI3K/Akt activation
  also stimulates metabolic enzymes (i. e. hexokinase) to drive tumour metabolism.
  Cancer cells are reliant on mitochondrial metabolism for the increase of glucose
  to satisfy increased energy requirements. Glucose enters the cell via the glucose
  transporter (GLUT) to initiate glycolysis. HKII binds to voltage-dependent anion
  channel (VDAC) and adenine nucleotide translocase (ANT) to form a complex. Thus,
  the simultaneous inhibition of the EGFR signalling pathway and tumour metabolism
  pathway was explored. Gefitinib binds to the tyrosine kinase domain of EGFR to inhibit
  the activation of EGFR signalling whilst PENAO is transported across the plasma
  membrane and enters the mitochondrial matrix to interact with Cys57 and Cys257 residues
  in the ANT, perturb the mitochondrial permeability transition pore and decrease
  ATP delivery to the cancer cell.'
pmcid: PMC6967775
papertitle: The synergistic inhibitory effect of combining therapies targeting EGFR
  and mitochondria in sarcomas.
reftext: Xiaochun Wang, et al. Oncotarget. 2020 Jan 7;11(1):46-61.
pmc_ranked_result_index: '9605'
pathway_score: 0.9555419
filename: oncotarget-11-46-g001.jpg
figtitle: Synergistic inhibitory effect of combining therapies targeting EGFR and
  mitochondria in sarcomas
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6967775__oncotarget-11-46-g001.html
  '@type': Dataset
  description: 'In cancer cells, EGF or EGF-related ligands bind to EGFR and phosphorylate
    tyrosine kinase residues, activating three major signal transduction pathways:
    MAPK, PI3K/Akt and JAK/STAT, which promote cell survival. Upregulated PI3K/Akt
    activation also stimulates metabolic enzymes (i. e. hexokinase) to drive tumour
    metabolism. Cancer cells are reliant on mitochondrial metabolism for the increase
    of glucose to satisfy increased energy requirements. Glucose enters the cell via
    the glucose transporter (GLUT) to initiate glycolysis. HKII binds to voltage-dependent
    anion channel (VDAC) and adenine nucleotide translocase (ANT) to form a complex.
    Thus, the simultaneous inhibition of the EGFR signalling pathway and tumour metabolism
    pathway was explored. Gefitinib binds to the tyrosine kinase domain of EGFR to
    inhibit the activation of EGFR signalling whilst PENAO is transported across the
    plasma membrane and enters the mitochondrial matrix to interact with Cys57 and
    Cys257 residues in the ANT, perturb the mitochondrial permeability transition
    pore and decrease ATP delivery to the cancer cell.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - EGFR
  - SLC2A1
  - HRAS
  - KRAS
  - NRAS
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - EIF2AK3
  - WDTC1
  - HK2
  - ARAF
  - BRAF
  - RAF1
  - AKT2
  - AKT3
  - AKT1
  - MAP2K1
  - MAP2K2
  - STAT1
  - STAT5A
  - STAT6
  - STAT2
  - STAT3
  - STAT4
  - STAT5B
  - MAPK3
  - MAPK1
  - MTOR
  - Glucose
  - gefitinib
  - ADP
genes:
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: GLUT
  symbol: GLUT
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A1
  entrez: '6513'
- word: ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: РЕК
  symbol: PEK
  source: hgnc_alias_symbol
  hgnc_symbol: EIF2AK3
  entrez: '9451'
- word: ADP
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
- word: HKII
  symbol: HK2
  source: hgnc_symbol
  hgnc_symbol: HK2
  entrez: '3099'
- word: raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
chemicals:
- word: Glucose
  source: MESH
  identifier: D005947
- word: gefitinib
  source: MESH
  identifier: C419708
- word: ADP
  source: MESH
  identifier: D000244
diseases: []
---
